NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 36 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,250 | +176.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,900 | -44.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,400 | -24.9% | 10,000 | -28.6% | 0.00% | 0.0% |
| Q4 2022 | $4,526 | -24.6% | 14,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $6,000 | 0.0% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | -66.7% | 14,000 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $18,000 | 0.0% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $18,000 | -33.3% | 14,000 | +6.9% | 0.00% | -42.9% |
| Q3 2021 | $27,000 | +35.0% | 13,100 | +1.9% | 0.01% | +40.0% |
| Q2 2021 | $20,000 | -23.1% | 12,850 | +11.7% | 0.01% | -28.6% |
| Q1 2021 | $26,000 | -7.1% | 11,500 | +2.2% | 0.01% | -12.5% |
| Q4 2020 | $28,000 | +7.7% | 11,250 | +7.1% | 0.01% | -11.1% |
| Q3 2020 | $26,000 | – | 10,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 55,000 | $179,000 | 0.09% |
| WEDBUSH SECURITIES INC | 180,945 | $590,000 | 0.09% |
| Brown Advisory Securities, LLC | 28,000 | $91,000 | 0.03% |
| FNY Managed Accounts LLC | 8,000 | $26,080,000 | 0.02% |
| FT Options LLC | 10,000 | $26,000 | 0.02% |
| WEBSTER BANK, N. A. | 40,000 | $130,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 30,907 | $101,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $82,000 | 0.00% |
| NATIONAL PLANNING CORP | 11,000 | $32,000 | 0.00% |
| Virtu KCG Holdings LLC | 24,705 | $81,000 | 0.00% |